3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase NA
1
Phase 2
1
Phase 1
1
Status
Completed
252
Terminated
123
Recruiting
105
Unknown
64
Active not recruiting
42
Withdrawn
24
Not yet recruiting
22
Enrolling by invitation
3
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
13
Neoplasms
12
Neoplasm Metastasis
9
Melanoma
7
Prostatic Neoplasms
6
Ovarian Neoplasms
6
Myelodysplastic Syndromes
6
Breast Neoplasms
6
Pancreatic Neoplasms
5
Lung Neoplasms
5
Glioma
5
Colorectal Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Hematologic Neoplasms
4
Glioblastoma
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma
3
Head and Neck Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Non-Small-Cell Lung
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Solid Tumors
2
Solid Tumor
2
Sarcoma
2
Osteosarcoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, B-Cell
2
Interventions
zanubrutinib
1
tazemetostat
1
obinutuzumab
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Suspended
×
Recurrence
×
Clear all
NCT06824701
2026-04-06
TARZAN
University of Utah
Phase 1
Suspended
24 enrolled